Author: Cattell Emma Arance Ana Middleton Mark
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.3, Iss.6, 2002-06, pp. : 693-700
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QOL benefits with palliative chemotherapy in ovarian cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. :
Use of palliative chemotherapy for newly-diagnosed incurable cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. :
Nitroglycerin improves chemotherapy outcomes in NSCLC
Inpharma, Vol. 1, Iss. 1528, 2006-01 ,pp. :
Colorectal Cancer in the Elderly: Is Palliative Chemotherapy of Value?
By Honecker F.
Drugs & Aging, Vol. 20, Iss. 1, 2003-01 ,pp. :